Skip to content
20-F

Annual Report (Foreign)

QIAGEN N.V. QGEN

0001015820-25-000027

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 222.29M sh
Long Term Debt FY 2024 · Dec 31, 2023 $921.82M
Short Term Investments FY 2024 · Dec 31, 2023 $389.7M
Cash And Equivalents FY 2024 · Dec 31, 2023 $668.08M
Current Liabilities FY 2024 · Dec 31, 2023 $1.08B
Current Assets FY 2024 · Dec 31, 2023 $2.15B
Total Assets FY 2024 · Dec 31, 2023 $6.12B
Shares Diluted FY 2024 · Dec 31, 2022 230.14M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $0
Capex FY 2024 · Dec 31, 2022 $129.22M
Operating Cash Flow FY 2024 · Dec 31, 2022 $715.26M
Eps Diluted FY 2024 · Dec 31, 2022 $1.84
Eps Basic FY 2024 · Dec 31, 2022 $1.86
Sga Expense FY 2024 · Dec 31, 2022 $129.73M
Net Income FY 2024 · Dec 31, 2022 $423.21M
Operating Income FY 2024 · Dec 31, 2022 $531.46M
Gross Profit FY 2024 · Dec 31, 2022 $1.38B
Cost Of Revenue FY 2024 · Dec 31, 2022 $756.96M
Revenue FY 2024 · Dec 31, 2022 $2.14B
Stockholders Equity FY 2024 · Dec 31, 2021 $3.1B